The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery.

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html
 

comments (0)

64 more from jameshebrew